Intellia Accused of Patent Infringement in Gene Editing Technology Lawsuit
![Seeking Alpha](https://store.livarava.com/8117481f-3d78-11ef-bfba-91148d8070a3.jpg)
Intellia Faces Legal Battle Over Patents
BlueAllele has recently filed a lawsuit against Intellia, accusing the company of infringing on three important gene editing technology patents.
The Allegations
In the lawsuit, BlueAllele claims that Intellia's actions constitute a violation of their patented technologies, sparking a legal dispute between the two entities.
This legal battle is closely watched by industry experts and investors as it has the potential to impact the gene editing technology landscape significantly.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.